Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,497,509
-$1,487,723 QoQ
Shares Held
269,515
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
1.68%
of 13F equity value
Holder Rank
#79
of 712 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SPHERA FUNDS MANAGEMENT LTD. holds $104,911,681 across 12 Drug Manufacturers - General names. SNY ranks #3 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIIB |
Biogen Inc.
|
96,626 | $20,877,013 | |
| 2 | AZN |
Astrazeneca PLC
|
62,530 | $11,856,938 | |
| 3 | SNY |
Sanofi
This page
|
269,515 | $11,497,509 | |
| 4 | LLY |
ELI LILLY & Co
|
8,040 | $9,643,418 | |
| 5 | NVS |
Novartis AG
|
50,000 | $7,836,000 | |
| 6 | ABBV |
AbbVie Inc.
|
30,256 | $7,613,619 | |
| 7 | MRK |
Merck & Co., Inc.
|
58,600 | $7,530,100 | |
| 8 | JNJ |
Johnson & Johnson
|
28,831 | $7,322,209 |
All Filings in SNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,497,509 | 269,515 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,985,232 | 269,515 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,606,896 | 239,515 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $10,361,108 | 219,515 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,604,769 | 219,515 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $16,888,401 | 304,515 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $18,545,158 | 384,515 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $23,600,349 | 409,515 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $21,810,467 | 449,515 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $24,276,429 | 499,515 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $24,840,880 | 499,515 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $26,793,984 | 499,515 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $28,540,858 | 529,515 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $28,816,206 | 529,515 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $27,097,311 | 559,515 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $46,175,860 | 1,214,515 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $42,336,136 | 846,215 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $49,923,786 | 972,415 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $54,278,340 | 1,083,400 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $40,660,314 | 843,400 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $44,413,444 | 843,400 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $49,356,134 | 997,900 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $56,190,400 | 1,120,000 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $57,176,000 | 1,120,000 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $42,408,400 | 970,000 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||